Markets Swiss stock market clearly up - clear countermovement
The Swiss stock market starts a recovery attempt on Tuesday. According to traders, statements by US President Trump on the possible imminent end of the Iran war are giving rise to hope worldwide.
10.03.2026, 10:07
SDA
The military objectives have largely been achieved and the war is "well ahead of schedule", Trump said. The US markets rose significantly in the immediate aftermath and stock markets in Asia also rose. Volatility could increase again quickly, said one trader. But for now, "some pressure has been taken out of the cauldron".
The energy market also eased after Trump's comments. The price of Brent crude oil, which had risen to almost 120 dollars on Monday night, stood at 94 dollars in the early morning. In addition to hopes of an end to the war, the G7's plans to release strategic reserves if necessary also helped.
Broad recovery
After the sell-off of the past few days, the SMI gained 1.4 percent to 13,180 points at around 09:45. Of the 20 SMI stocks, 17 are up and only 3 are down. The broad SPI gained 1.6 percent to 18,256 points.
Investors on the international markets also breathed a sigh of relief. The Nikkei in Japan rose by almost 3 percent, while the heavily battered Kospi in South Korea even gained over 5 percent. And in Frankfurt, the DAX recovered by 2 percent in early trading and the London FTSE-100 by 1.2 percent. Bitcoin has also fought its way back above the 70,000 dollar mark.
Novartis puts the brakes on
In general, the Swiss market is showing a broad recovery, with the exception of a few outliers. For example, 16 of the 20 SMI stocks gained more than 1 percent, six of them even more than 3 percent. Stocks from energy-intensive sectors, which had suffered heavily the previous day, are particularly strong. Financial stocks such as UBS are also in demand.
Today's dividend payout by Novartis (-1.4%) is a minor drag on the SMI. This is a drag on the market as a whole.
Among the mid-caps, Lindt & Sprüngli (-9.2%) fell massively following its figures. The lowered targets for 2026 are not well received.
